J. Smith

Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.

E. Crawford, J. Costanzi, M. al-Sarraf, 1985, Cancer treatment reports.

Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial.

L. Recht, M. Mehta, R. Gervais, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

J. Sosman, G. Weiss, M. Ernstoff, 2002, Journal of Cancer Research and Clinical Oncology.

Phase I and pharmacologic studies of topotecan in patients with impaired hepatic function.

L. Grochow, D. Ettinger, R. Donehower, 1996, Journal of the National Cancer Institute.